Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
Launched by NATIONAL JEWISH HEALTH · Dec 1, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The TrANsMIt study is looking into how nontuberculous mycobacteria (NTM) infections spread in healthcare settings. Researchers want to understand if patients in a suspected outbreak are closely related based on genetic testing and if these infections could be passed from one patient to another. They will also investigate if the healthcare environment contributes to these infections. If you're an adult (30 years or older) who has been diagnosed with NTM or has had a positive test for it, you might be eligible to participate in this study.
Participants will fill out a questionnaire about their background and health history, which will help researchers gather important information. The study is currently recruiting participants, and it's open to anyone regardless of gender. If you join, you’ll be contributing to important research that could help improve our understanding of how these infections spread in hospitals and clinics.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female participant of any age who has a history of NTM or a first positive NTM culture collected as part of routine clinical care from expectorated sputum, induced sputum and/or bronchoalveolar lavage.
- Exclusion Criteria:
- • No NTM respiratory culture
About National Jewish Health
National Jewish Health is a leading research and treatment institution dedicated to understanding and addressing respiratory, allergic, and immune-related conditions. Renowned for its pioneering clinical trials, the organization combines innovative research with exceptional patient care, focusing on advancing medical knowledge and improving treatment outcomes. With a commitment to excellence, National Jewish Health collaborates with academic and industry partners to develop novel therapies and enhance patient experiences, making significant contributions to the field of respiratory and immune health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Denver, Colorado, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported